Legal Alliance Company has become one of the four partners of the EBA Healthcare Committee in 2017. It was decided so by the Board of the Committee upon the tender results in January.
The EBA Healthcare Committee unites 60 companies engaged in the development, manufacture and supply of medicinal products and medical devices to Ukrainian market, as well as which provide for clinical trials in Ukraine.
From February 7th, 2017 Legal Alliance team will participate in the analysis of regulations in the pharmaceutical sector, provide legal support to the development of the Committee positions, drafts of legislative initiatives or changes in existing legislation, and other issues that require legal examination.
Dmytro Aleshko, head of Pharmaceutical Regulatory department of Legal Alliance Company commented on partnership with the EBA Committee as follows: "Today, the EBA is one of the most powerful mouthpieces of businesses operating in Ukraine. Optimization of the investment climate in the country is our common strategic goal. We appreciate the attention the Board of the EBA Healthcare Committee paid to our experience, and will try to live up to trust in us, and provide adequate legal support to the Committee members".
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
